- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 23
  num_fold: 3763
  S: 2995
  I: 684
  R: 84
  median_fold: 1.8
  percent: 7.1
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 20
  num_fold: 615
  S: 464
  I: 129
  R: 22
  median_fold: 2.5
  percent: 1.2
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 150
  num_fold: 16026
  S: 11829
  I: 3339
  R: 858
  median_fold: 2.4
  percent: 30.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 35
  num_fold: 1605
  S: 1045
  I: 506
  R: 54
  median_fold: 2.9
  percent: 3.0
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 47
  num_fold: 3462
  S: 2202
  I: 1010
  R: 250
  median_fold: 3.9
  percent: 6.5
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 5
  num_fold: 116
  S: 83
  I: 26
  R: 7
  median_fold: 4.1
  percent: 0.22
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.29
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.026
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 58
  num_fold: 5378
  S: 3779
  I: 1342
  R: 257
  median_fold: 2.3
  percent: 10.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 334
  S: 241
  I: 74
  R: 19
  median_fold: 3.0
  percent: 0.63
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 15
  num_fold: 725
  S: 440
  I: 263
  R: 22
  median_fold: 4.2
  percent: 1.4
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 7
  num_fold: 688
  S: 258
  I: 177
  R: 253
  median_fold: 9.0
  percent: 1.3
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 43
  S: 41
  I: 2
  R: 0
  median_fold: 2.1
  percent: 0.081
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 29
  num_fold: 1704
  S: 1010
  I: 478
  R: 216
  median_fold: 4.0
  percent: 3.2
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 10
  num_fold: 300
  S: 243
  I: 54
  R: 3
  median_fold: 1.5
  percent: 0.57
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 342
  S: 96
  I: 246
  R: 0
  median_fold: 6.8
  percent: 0.65
  priority: 3
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 9
  num_fold: 609
  S: 324
  I: 164
  R: 121
  median_fold: 1.8
  percent: 1.1
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 32
  S: 24
  I: 6
  R: 2
  median_fold: 2.8
  percent: 0.06
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 142
  S: 28
  I: 114
  R: 0
  median_fold: 5.7
  percent: 0.27
  priority: 6
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 81
  S: 70
  I: 11
  R: 0
  median_fold: 1.3
  percent: 0.15
  priority: 7
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 6
  num_fold: 264
  S: 183
  I: 77
  R: 4
  median_fold: 1.9
  percent: 0.5
  priority: 8
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 499
  S: 100
  I: 398
  R: 1
  median_fold: 20.0
  percent: 0.94
  priority: 8
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.9
  priority: 9
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 172
  S: 152
  I: 0
  R: 20
  median_fold: 2.4
  percent: 0.32
  priority: 9
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.25
  priority: 10
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 70
  S: 2
  I: 68
  R: 0
  median_fold: 8.0
  percent: 0.13
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 14
  num_fold: 1784
  S: 1227
  I: 543
  R: 14
  median_fold: 3.3
  percent: 3.4
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 5
  num_fold: 121
  S: 13
  I: 68
  R: 40
  median_fold: 8.0
  percent: 0.23
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 912
  S: 425
  I: 487
  R: 0
  median_fold: 5.1
  percent: 1.7
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 404
  S: 253
  I: 151
  R: 0
  median_fold: 3.6
  percent: 0.76
  priority: 10
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 148
  S: 110
  I: 34
  R: 4
  median_fold: 2.3
  percent: 0.28
  priority: 11
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 64
  S: 40
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.12
  priority: 13
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 6
  num_fold: 459
  S: 311
  I: 106
  R: 42
  median_fold: 2.7
  percent: 0.87
  priority: 14
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 15
  num_fold: 852
  S: 666
  I: 124
  R: 62
  median_fold: 2.4
  percent: 1.6
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 6
  num_fold: 175
  S: 126
  I: 43
  R: 6
  median_fold: 2.6
  percent: 0.33
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 306
  S: 196
  I: 109
  R: 1
  median_fold: 3.6
  percent: 0.58
  priority: 15
- vaccine: mRNA-1273 + mRNA-1273.351
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 237
  S: 222
  I: 11
  R: 4
  median_fold: 2.2
  percent: 0.45
  priority: 18
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 13
  S: 0
  I: 10
  R: 3
  median_fold: 15.0
  percent: 0.025
  priority: 25
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 142
  S: 42
  I: 82
  R: 18
  median_fold: 6.6
  percent: 0.27
  priority: 31
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 451
  S: 352
  I: 97
  R: 2
  median_fold: 1.6
  percent: 0.85
  priority: 34
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.011
  priority: 39
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 5
  num_fold: 278
  S: 221
  I: 39
  R: 18
  median_fold: 2.1
  percent: 0.52
  priority: 1000
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 280
  S: 218
  I: 62
  R: 0
  median_fold: 2.8
  percent: 0.53
  priority: 1000
